Demerol (meperidine) is actually weaker than morphine, not stronger. By injection, you need about 75 mg of Demerol to match the pain relief of just 10 mg of morphine. Taken by mouth, the gap widens even further: 300 mg of Demerol equals roughly 30 mg of oral morphine. That makes morphine approximately 7.5 times more potent by injection and 10 times more potent by mouth.
How the Potency Comparison Works
Doctors compare opioid painkillers using something called equianalgesic dosing, which simply means “how many milligrams of drug A give you the same pain relief as drug B.” Morphine is the standard reference point. Every other opioid is measured against a baseline of 10 mg of injected morphine or 30 mg of oral morphine.
Demerol requires significantly higher doses to reach that same level of relief. This doesn’t mean it can’t control pain, but it does mean you need much more of it. And because Demerol breaks down into a toxic byproduct in the body (more on that below), needing higher doses creates a compounding safety problem that morphine doesn’t share.
Why Demerol Carries Unique Risks
When your liver processes Demerol, it produces a breakdown product called normeperidine. This metabolite lingers in the body with a half-life of about 20.6 hours, meaning it takes nearly a full day for just half of it to clear. With repeated doses, normeperidine builds up and can overstimulate the nervous system, causing agitation, muscle twitching, tremors, and seizures. Morphine doesn’t produce this kind of toxic buildup.
The accumulation risk is especially high for people with kidney or liver problems, since both organs play a role in clearing the metabolite. In these patients, even standard doses can reach dangerous levels. The Institute for Safe Medication Practices specifically recommends avoiding Demerol in older adults because of this neurotoxic metabolite. The 2023 Beers Criteria, a widely used guide for safe prescribing in older patients, lists Demerol as posing a higher risk of neurotoxicity and delirium compared to other opioids.
A Dangerous Drug Interaction Morphine Doesn’t Have
Demerol has a unique and potentially fatal interaction with a class of antidepressants called MAOIs. Even a normal dose of Demerol given to someone who has taken an MAOI within the past 14 days can trigger severe reactions: coma, dangerously low blood pressure, respiratory failure, or a condition called serotonin syndrome marked by high fever, rapid heart rate, sweating, tremors, and confusion. The FDA labels this combination as strictly contraindicated.
Normeperidine itself has properties that affect serotonin levels, which means Demerol carries a broader risk of serotonin syndrome even beyond MAOI interactions. Morphine does not share this serotonin-related risk profile.
Demerol Triggers More Histamine Release
Both drugs cause the body to release histamine, which can lead to itching, skin flushing, and drops in blood pressure. But Demerol does this more frequently. In a double-blind study comparing several opioids, 31% of patients given Demerol developed clinical signs of histamine release, including low blood pressure and rapid heart rate, compared to a lower rate with morphine. The severity of blood pressure drops correlated directly with how much histamine was released.
Why Demerol Has Fallen Out of Favor
Demerol was once one of the most commonly prescribed opioids in hospitals, but medical guidelines have steadily moved away from it. The combination of lower potency, a toxic metabolite, seizure risk, dangerous drug interactions, and more frequent histamine reactions makes it a poor choice compared to alternatives. The Beers Criteria goes further, noting that Demerol is considered ineffective at commonly used oral doses, meaning patients often don’t get adequate pain relief at the doses considered safe enough to prescribe.
Today, Demerol’s main clinical role has narrowed considerably. It still sees occasional use for treating post-surgical shivering, where it has a specific advantage over other opioids. But for routine pain management, particularly anything beyond short-term use, morphine and other opioids have largely replaced it. Repeated dosing over more than 48 hours significantly raises the chance of normeperidine accumulation and the neurological problems that come with it.
So while Demerol’s reputation from decades of widespread hospital use might suggest it’s a powerful painkiller, the pharmacology tells a different story. Milligram for milligram, morphine provides substantially more pain relief with a cleaner safety profile.